ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "knowledge"

  • Abstract Number: 172 • 2020 Pediatric Rheumatology Symposium

    Improved Self-efficacy and Knowledge in Pediatric Rheumatology Among General Pediatric Residents Following the Introduction of a Standardized Teaching Series

    Elizaveta Limenis1, Alhanouf Alsaleem 2, Herman Tam 3, Piya Lahiry 1, Kate Neufeld 4 and Shirley Tse 5, 1Hospital for Sick Children, Toronto, Canada, 2KFSH&RC, RiYADH, Saudi Arabia, 3The Hospital for Sick Children, Toronto, Canada, 4University of Toronto, The Hospital for Sick Children, Toronto, Canada, 5SickKids, Toronto, Canada

    Background/Purpose: Self-efficacy and knowledge in core pediatric rheumatology (PR) topics are generally low among pediatric residents before their mandatory rotations in PR. The teaching style…
  • Abstract Number: 2350 • 2018 ACR/ARHP Annual Meeting

    Examining Ethnic Differences in Osteoarthritis (OA) Patients’ Knowledge and Attitudes Regarding Prescription Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

    Hana Masood1, Michael J. Hannon2, C. Kent Kwoh1, Jazmin Dagnino3 and Ernest Vina4, 1Medicine, Division of Rheumatology, University of Arizona School of Medicine, University of Arizona Arthritis Center, Tucson, AZ, 2Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, 3University of Arizona Arthritis Center, Tucson, AZ, 4University of Arizona School of Medicine, University of Arizona Arthritis Center, Tucson, AZ

    Background/Purpose: NSAIDs are commonly prescribed for the treatment of OA. While there are documented differences between Hispanics and non-Hispanic whites (NHWs) in their treatment preferences…
  • Abstract Number: 2262 • 2017 ACR/ARHP Annual Meeting

    Knowledge, Beliefs and Concerns about Osteoporosis – a Qualitative Synthesis

    Jude des Bordes1, Seema Prasad2, Gregory Pratt3, Maria Suarez-Almazor1 and Maria A. Lopez-Olivo1, 1Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA, Houston, TX, 2Gastroenterology Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA, Houston, TX, 3Research Medical Library, The University of Texas MD Anderson Cancer Center, Houston, TX, USA, Houston, TX

    Background/Purpose: Educating patients with osteoporosis about bone health could increase their knowledge and self-efficacy. These can help them adopt healthy lifestyles to prevent osteoporosis-associated fractures.…
  • Abstract Number: 100 • 2017 ACR/ARHP Annual Meeting

    Improving Internal Medicine Resident’s Knowledge through a Web-Based Musculoskeletal Educational Module

    Uzma Haque1,2, Clifton O. Bingham III3 and Allan C. Gelber4, 1Rheumatology, Johns Hopkins School of Medicine, Lutherville, MD, 2Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 3Rheumatology, Johns Hopkins University, Baltimore, MD, 4Johns Hopkins University School of Medicine, Baltimore, MD

    Background/Purpose: Musculoskeletal (MSK) complaints account for 15-30% of the ambulatory care visits in the United States. MSK training during Internal Medicine (IM) residency remains suboptimal,…
  • Abstract Number: 2021 • 2016 ACR/ARHP Annual Meeting

    Development of an Item Bank on Disease and Treatment Associated Knowledge of Rheumatoid Arthritis to Improve Patient Engagement in Care

    Marieke J. de Jonge1, Martijn A.H. Oude Voshaar2, Anita M.P. Huis1, Mart A.F.J. van de Laar2, Marlies E.J.L. Hulscher1 and Piet L.C.M. van Riel1,3, 1Radboud university medical center, Radboud Institute for Health Sciences, IQ healthcare, Nijmegen, Netherlands, 2University of Twente, Department of Psychology, Health and Technology, Enschede, Netherlands, 3Bernhoven, Department of Rheumatology, Uden, Netherlands

    Background/Purpose: Patient involvement and personalization of healthcare have become increasingly important in managing chronic diseases. Knowledge about their disease and its treatment is an important…
  • Abstract Number: 1202 • 2015 ACR/ARHP Annual Meeting

    Knowledge and Perception of Cardiovascular Disease Risk in Patients with Psoriatic Disease

    Dennis Wong1, Daniel Pereira2, Sutha Shanmugarajah1, Renise Ayearst2, Dafna Gladman2, Cheryl Rosen3 and Vinod Chandran2, 1University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 2Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 3Dermatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada

    Background/Purpose: The prevalence of cardiovascular diseases (CVD) is higher in patients with psoriatic disease. Psoriatic disease is known to be an independent risk factor for…
  • Abstract Number: 1448 • 2014 ACR/ARHP Annual Meeting

    A Questionnaire Assessment of Knowledge about Methotrexate of Patients with Rheumatoid Arthritis

    Françoise Fayet1, Carine Savel1, Malory Rodere2, Bruno Pereira3, Dihya Abdi1, Marion Couderc Sr.4, Sylvain Mathieu5, Anne Tournadre6, Sandrine Malochet-Guinamand6, Martin Soubrier7 and Jean Jacques Dubost8, 1Rheumatology, CHU Gabriel-Montpied, Clermont-ferrand, France, 2Rheumatology, CHU Gabriel-Montpied, Clermont-Ferrand, France, 3Clinical research department, Clermont-Ferrand, France, 4Chu G.Montpied, Clermont Ferrand, France, 5Hopital Gabriel Montpied, Clermont Ferrand, France, 6Rheumatology CHU Gabriel Montpied, Clermont-Ferrand, France, 7COMEDRA trial group, Paris, France, 8Rheumatology, CHU G.-Montpied, Clermont-Ferrand, France

    Background/Purpose Methotrexate is the reference treatment for rheumatoid arthritis (RA).  It has potentially serious side effects which can be prevented by an improvement in patient’s…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology